08:00 AM EDT, 06/10/2024 (MT Newswires) -- C4 Therapeutics ( CCCC ) said Monday it has appointed Ron Cooper as chairman of the board, succeeding Bruce Downey.

Cooper joins the company from Albireo Pharma, where he most recently served as president and chief executive, C4 Therapeutics ( CCCC ) added.

Downey will remain a board member, the biopharmaceutical firm said.

Shares of the company were up 5.6% in recent Monday premarket activity.

Price: 4.9200, Change: +0.26, Percent Change: +5.58